Moritz Mall
Mannheim, BW 68159, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.
Journal: Nature
Published: March 23, 2025
Reprogramming Stars #18: Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall.
Journal: Cellular reprogramming
Published: October 30, 2024
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.
Journal: Nature communications
Published: October 23, 2024
Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.
Journal: Cell death & disease
Published: July 10, 2024
Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 06, 2024
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.
Journal: Nature
Published: October 05, 2023
Canalizing cell fate by transcriptional repression.
Journal: Molecular systems biology
Published: September 19, 2023
A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs.
Journal: NPJ precision oncology
Published: January 23, 2023
MEOX2 homeobox gene promotes growth of malignant gliomas.
Journal: Neuro-oncology
Published: April 25, 2022
Last Updated: 09/26/2026